Biotech ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action – EIGR December 31, 2022
Biotech BLRX SHAREHOLDER ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX December 30, 2022
Biotech ROSEN, LEADING TRIAL ATTORNEYS, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action – EIGR December 30, 2022
Biotech CLASS ACTION UPDATE for SEDG, EIGR and CURV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders December 30, 2022
Biotech OTC Markets Group Grants Evofem Additional Time to File Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2022 December 29, 2022
Biotech SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Catalyst Biosciences, Inc. Merger December 29, 2022
Biotech Biotech Stock Roundup: GILD’s HIV Drug Approval, PRQR Surges on LLY Deal & More December 29, 2022